For all journalist enquiries please contact:
Isabelle Boscaro-Clarke
Head of Communications
+44 (0) 1235 778130
Follow us on Twitter Watch us on Vimeo Follow us on LinkedInFollow us on Facebook
Diamond scientists and researchers have worked with a wide community of companies, universities, and delegates to discover new insights into COVID-19. Find key partner information in the boilerplates below:
Diamond Light Source is the UK’s national synchrotron, providing industrial and academic user communities with access to state-of-the-art analytical tools to enable world-changing science. Shaped like a huge ring, it works like a giant microscope, accelerating electrons to near light speeds, to produce a light 10 billion times brighter than the Sun, which is then directed off into 33 laboratories known as ‘beamlines’. In addition to these, Diamond offers access to several integrated laboratories including the Electron Bio-imaging Centre (eBIC) and the Electron Physical Science Imaging Centre (ePSIC).
Diamond serves as an agent of change, addressing 21st century challenges such as disease, clean energy, food security and more. Since operations started, more than 14,000 researchers from both academia and industry have used Diamond to conduct experiments, with the support of approximately 700 world-class staff. More than 9,000 scientific articles have been published by our users and scientists.
Funded by the UK Government through the Science and Technology Facilities Council (STFC), and by the Wellcome Trust, Diamond is one of the most advanced scientific facilities in the world, and its pioneering capabilities are helping to keep the UK at the forefront of scientific research.
For more information visit us on www.diamond.ac.uk or follow us on Twitter @DiamondLightSou.
Exscientia is a global Artificial Intelligence (AI)-driven drug discovery company. Centaur Chemist™ platform, fusing the power of the original AI with the experience of seasoned drug hunters, enables breakthrough productivity gains as well as new approaches to improve drug efficacy. Novel compounds are automatically designed and prioritised for synthesis by its AI systems, which rapidly evolve compounds towards the desired candidate criteria for clinical development. For more information visit us on www.exscientia.ai or follow us on Twitter @exscientialtd.
Calibr was founded on the principle that the creation of new medicines can be accelerated by pairing world-class biomedical research with state-of-the-art drug discovery and development capabilities. Leveraging the unique scientific framework of Scripps Research, Calibr has created a portfolio of drug candidates based on Scripps technologies, and is shaping a new paradigm for advancing nonprofit biomedical research to impact patients while re-investing in further innovative research. For more information visit us on www.calibr.org or follow us on Twitter @scrippsresearch.
PostEra Inc. is a new biotechnology company that integrates molecular design with chemical synthesis. The team saw some great data produced by the Diamond Light Source and wanted to get involved; they are working pro bono on the project. PostEra realized that it had both the tools and bandwidth to help lead COVID Moonshot initative. Like many companies around the world, they are seeking opportunities to contribute to combatting COVID-19, and see this pro bono involvement as the best route to doing so.
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2022 Diamond Light Source
Diamond Light Source Ltd
Diamond House
Harwell Science & Innovation Campus
Didcot
Oxfordshire
OX11 0DE
Diamond Light Source® and the Diamond logo are registered trademarks of Diamond Light Source Ltd
Registered in England and Wales at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom. Company number: 4375679. VAT number: 287 461 957. Economic Operators Registration and Identification (EORI) number: GB287461957003.